Knowledge of a newly discovered genetic disorder can lead way to development of new diabetes drugs. This is shown in a study co-led by SciLifeLab researcher Anna Wedell (Karolinska Institute) and published in the journal Diabetes.

The newly discovered genetic disorder, with high levels of lactic acid and low levels of the amino acid methionine in the blood, can cause tissue damage, respiratory effects and even have a fatal outcome if left untreated.

“We discovered that the symptoms were due to a mutation in the gene that encodes the protein TXNIP [thioredoxin interacting protein], which had never previously been described in humans. Based on the results in animal models, this protein has been suggested as a possible target for new diabetes drugs, since overexpressing TXNIP in mice induces diabetes, while a lack of TXNIP protects against diabetes,” says Professor Anna Wedell in a news article by Karolinska Institutet.

What would happen in humans if the protein TXNIP were absent has previously not been known. The results of the new study provide insights that strengthen the hypothesis that TXNIP may be a potential target for drug treatment in diabetes, provided that any high lactate levels as a result of such treatment can be managed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Ok!Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT